Literature DB >> 19782133

Properties of melt extruded enteric matrix pellets.

Sandra U Schilling1, Navnit H Shah, A Waseem Malick, James W McGinity.   

Abstract

The objective of this study was to investigate the properties of enteric matrix pellets that were prepared by hot-melt extrusion in a one-step, continuous process. Five polymers (Eudragit) L100-55, L100 and S100, Aqoat grades LF and HF) were investigated as possible matrix formers, and pellets prepared with Eudragit S100 demonstrated superior gastric protection and acceptable processibility. Extruded pellets containing Eudragit S100 and up to 40% theophylline released less than 10% drug over 2h in acid, however, the processibility and yields were compromised by the high amounts of the non-melting drug material in the formulation. Efficient plasticization of Eudragit S100 was necessary to reduce the polymer's glass transition temperature and melt viscosity. Five compounds including triethyl citrate, methylparaben, polyethylene glycol 8000, citric acid monohydrate and acetyltributyl citrate were investigated in terms of plasticization efficiency and preservation of the delayed drug release properties. The aqueous solubility of the plasticizer and its plasticization efficiency impacted the drug release rate from the matrix pellets. The use of water-soluble plasticizers resulted in a loss of gastric protection, whereas low drug release rates in acid were found for pellets containing insoluble plasticizers or no plasticizer, independent of the extent of Eudragit S100 plasticization. The release rate of theophylline in buffer pH 7.4 was faster for pellets that were prepared with efficient plasticizers. The microstructure and solid-state properties of plasticized pellets were further investigated by scanning electron microscopy and powder X-ray diffraction. Pellets prepared with efficient plasticizers (TEC, methylparaben, PEG 8000) exhibited matrices of low porosity, and the drug was homogeneously dispersed in its original polymorphic form. Pellets containing ATBC or citric acid monohydrate had to be extruded at elevated temperature and showed physical instabilities in the form of recrystallization at room temperature. Enteric matrix pellets with a diameter below 1mm and containing 30% theophylline could be successfully prepared by hot-melt extrusion when Eudragit S100 plasticized with either TEC or methylparaben was employed as the matrix material. Copyright (c) 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19782133     DOI: 10.1016/j.ejpb.2009.09.008

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  13 in total

1.  Miniaturization in pharmaceutical extrusion technology: feeding as a challenge of downscaling.

Authors:  Christian Muehlenfeld; Markus Thommes
Journal:  AAPS PharmSciTech       Date:  2011-12-09       Impact factor: 3.246

Review 2.  Challenges and Strategies in Thermal Processing of Amorphous Solid Dispersions: A Review.

Authors:  Justin S LaFountaine; James W McGinity; Robert O Williams
Journal:  AAPS PharmSciTech       Date:  2015-08-26       Impact factor: 3.246

3.  Ethylcellulose-based matrix-type microspheres: influence of plasticizer RATIO as pore-forming agent.

Authors:  C Tuba Sengel-Turk; Canan Hascicek; Nursin Gonul
Journal:  AAPS PharmSciTech       Date:  2011-09-02       Impact factor: 3.246

4.  Optimization of hot melt extrusion parameters for sphericity and hardness of polymeric face-cut pellets.

Authors:  Abdullah S Alshetaili; Bjad K Almutairy; Saad M Alshahrani; Eman A Ashour; Roshan V Tiwari; Sultan M Alshehri; Xin Feng; Bader B Alsulays; Soumyajit Majumdar; Nigel Langley; Karl Kolter; Andreas Gryczke; Scott T Martin; Michael A Repka
Journal:  Drug Dev Ind Pharm       Date:  2016-05-04       Impact factor: 3.225

5.  Interpolyelectrolyte complexes of Eudragit® EPO with hypromellose acetate succinate and Eudragit® EPO with hypromellose phthalate as potential carriers for oral controlled drug delivery.

Authors:  Balamurugan Jeganathan; Vijayalakshmi Prakya
Journal:  AAPS PharmSciTech       Date:  2015-01-16       Impact factor: 3.246

6.  Continuous Manufacturing of Ketoprofen Delayed Release Pellets Using Melt Extrusion Technology: Application of QbD Design Space, Inline Near Infrared, and Inline Pellet Size Analysis.

Authors:  Anh Q Vo; Gerd Kutz; Herman He; Sagar Narala; Suresh Bandari; Michael A Repka
Journal:  J Pharm Sci       Date:  2020-09-08       Impact factor: 3.534

Review 7.  Melt extrusion with poorly soluble drugs - An integrated review.

Authors:  Michael A Repka; Suresh Bandari; Venkata Raman Kallakunta; Anh Q Vo; Haley McFall; Manjeet B Pimparade; Ajinkya M Bhagurkar
Journal:  Int J Pharm       Date:  2017-11-02       Impact factor: 5.875

8.  Chronotherapeutic Drug Delivery of Ketoprofen and Ibuprofen for Improved Treatment of Early Morning Stiffness in Arthritis Using Hot-Melt Extrusion Technology.

Authors:  Nagi Reddy Dumpa; Sandeep Sarabu; Suresh Bandari; Feng Zhang; Michael A Repka
Journal:  AAPS PharmSciTech       Date:  2018-07-02       Impact factor: 3.246

9.  Response surface methodology and process optimization of sustained release pellets using Taguchi orthogonal array design and central composite design.

Authors:  Gurinder Singh; Roopa S Pai; V Kusum Devi
Journal:  J Adv Pharm Technol Res       Date:  2012-01

10.  Optimization of pellets containing solid dispersion prepared by extrusion/spheronization using central composite design and desirability function.

Authors:  Gurinder Singh; Roopa S Pai; V Kusum Devi
Journal:  J Young Pharm       Date:  2012-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.